French pharmaceutical group expands precision oncology portfolio with promising pediatric brain cancer therapy
California, USA, 10 March 2026 - Global pharmaceutical company Servier has announced an agreement to acquire US-based Day One Biopharmaceuticals in a deal valued at $2.5 billion...
A new enterprise partnership aims to improve staffing efficiency and patient safety, even as legal concerns remain in focus.
2 March 2026, United States – Ardent Health announced a major step in its digital journey by partnering with hellocare.ai to...
Why Sonova’s strong earnings have not yet changed its U.S. market perception
New York, USA, 23 February 2026 – Sonova recently delivered a surprise that caught investors’ attention. The Swiss hearing-care company reported solid results and shared a confident outlook,...
$23 billion US investment plan gains momentum as new center aims to accelerate AI-driven drug discovery and advanced therapies
San Diego, California, 12 February 2026 – Novartis has officially begun construction on a major new global biomedical research center in...
Most search queries today see no click through - artificial intelligence gives responses on the spot. Six out of ten times,users take what they need right there. Companies in life sciences notice this shift, adapting fast.
Instead of only chasing...
Abstract
Organizations today operate in environments characterized by complex risk landscapes. Catastrophic events such as cyberattacks, natural disasters, pandemics and third-party failures pose significant threats to business operations. Business Continuity Management (BCM) and Disaster Recovery (DR) are critical topic for...
The promise of AI in biomedical research is undeniable. The current approach to delivering it is fundamentally flawed.
Walk into any research institution today and you'll find scientists using general-purpose AI chatbots. They're summarizing papers, exploring hypotheses, drafting literature reviews,...
NHS Blood and Transplant
The life sciences sector is undergoing one of the most profound transformations in its history. Advances in genomics, personalised medicine, automation, and digital platforms are redefining what is possible for patient care. At the same time,...
